Abogen Life Sciences (Shanghai) Co., Ltd.
Abogen Life Sciences (Shanghai) Co., Ltd.
Explore linked clinical trials.3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors | Solid Tumor, Adult | Recruiting | Phase 1 / Phase 2 | 2026-09-23 | NCT06088004 | |
| An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors | Solid Tumor | Recruiting | Early phase 1 | 2026-08-03 | NCT07680582 | |
| A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune Diseases | autoimmune disease, immune system disorder | Recruiting | Early phase 1 | 2026-03-24 | NCT06747156 |